InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: misiu143 post# 7200

Saturday, 11/05/2016 9:57:34 AM

Saturday, November 05, 2016 9:57:34 AM

Post# of 233152
Misiu, reduction in number of weeks would be like granting an informal approval. You are right in the sweet spot of what Nader is hoping for and anticipating. Conduct study on large patient population by enrolling rapidly on the coat tails of stellar data from the Adjunct. Disclose overwhelming positive interim Mono data. FDA says your done-that's enough proof.

You can bet BP and specifically Gilead will be watching closely after Adjunct knowing the ticking time bomb is the Mono Trial. Do they wait until the Mono Trial is complete and the FDA approves? This is the hand Nader is going to play IMO.

Once again he is 100% confident in the safety and efficacy of Pro-140. That is why he is focused on these milestones and not concerned about SP. I know many will disagree but it is also why he will not proceed with a reverse split- he doesn't have to and if he did he would run the risk of seriously watering down the shareholders ROI Unless it was timed perfectly. He's simply not willing to risk that at this point in the process. I for one agree with his logic.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News